Long-Term Liabilities: The sum of all non-current liabilities.
Hikma Pharmaceuticals Plc (HKMPF) had Long-Term Liabilities of $947.00M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.56B |
|
$1.33B |
|
$3.00B |
|
$5.55B |
|
$2.06B |
|
$842.00M |
|
|
Long-Term Liabilities |
$947.00M |
$3.00B |
|
$2.55B |
|
$1.33B |
|
$2.55B |
|
-- |
|
| Cash Flow Statement Financials | |
$161.00M |
|
$-215.00M |
|
$98.00M |
|
$188.00M |
|
$236.00M |
|
$48.00M |
|
$16.00M |
|
$-106.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|